An Adjudication Protocol for Severe Pneumonia

The NU SCRIPT Study Investigators

Research output: Contribution to journalArticlepeer-review

6 Scopus citations

Abstract

Background: Clinical end points that constitute successful treatment in severe pneumonia are difficult to ascertain and vulnerable to bias. The utility of a protocolized adjudication procedure to determine meaningful end points in severe pneumonia has not been well described. Methods: This was a single-center prospective cohort study of patients with severe pneumonia admitted to the medical intensive care unit. The objective was to develop an adjudication protocol for severe bacterial and/or viral pneumonia. Each episode of pneumonia was independently reviewed by 2 pulmonary and critical care physicians. If a discrepancy occurred between the 2 adjudicators, a third adjudicator reviewed the case. If a discrepancy remained after all 3 adjudications, consensus was achieved through committee review. Results: Evaluation of 784 pneumonia episodes during 593 hospitalizations achieved only 48.1% interobserver agreement between the first 2 adjudicators and 78.8% when agreement was defined as concordance between 2 of 3 adjudicators. Multiple episodes of pneumonia and presence of bacterial/viral coinfection in the initial pneumonia episode were associated with lower interobserver agreement. For an initial episode of bacterial pneumonia, patients with an adjudicated day 7-8 clinical impression of cure (compared with alternative impressions) were more likely to be discharged alive (odds ratio, 6.3; 95% CI, 3.5-11.6). Conclusions: A comprehensive adjudication protocol to identify clinical end points in severe pneumonia resulted in only moderate interobserver agreement. An adjudicated end point of clinical cure by day 7-8 was associated with more favorable hospital discharge dispositions, suggesting that clinical cure by day 7-8 may be a valid end point to use in adjudication protocols.

Original languageEnglish (US)
Article numberofad336
JournalOpen Forum Infectious Diseases
Volume10
Issue number7
DOIs
StatePublished - Jul 1 2023

Funding

Financial support. This work was supported by the National Institutes of Health, National Institute of Allergy and Infectious Diseases (AI135964). C.A.G. is supported by NIH awards T32HL076139 and F32HL162377. J.M.K. is supported by NIH/NHLBI K23HL146890. R.G.W. is supported by NIH awards U19AI135964, U01TR003528, P01HL154998, R01HL14988, R01LM013337. B.D.S. is supported by NIH awards R01HL149883, R01HL153122, P01HL154998, P01AG049665, and U19AI135964.

Keywords

  • adjudication
  • clinical
  • end point
  • pneumonia
  • severe

ASJC Scopus subject areas

  • Oncology
  • Infectious Diseases

Fingerprint

Dive into the research topics of 'An Adjudication Protocol for Severe Pneumonia'. Together they form a unique fingerprint.

Cite this